nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ACE—systemic scleroderma	0.29	1	CbGaD
Losartan—UGT1A10—Mycophenolate mofetil—systemic scleroderma	0.102	0.191	CbGbCtD
Losartan—ACE—Lisinopril—systemic scleroderma	0.072	0.135	CbGbCtD
Losartan—ACE—Captopril—systemic scleroderma	0.0539	0.101	CbGbCtD
Losartan—UGT2B7—Mycophenolic acid—systemic scleroderma	0.0436	0.0815	CbGbCtD
Losartan—UGT1A1—Mycophenolic acid—systemic scleroderma	0.0377	0.0705	CbGbCtD
Losartan—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.025	0.0468	CbGbCtD
Losartan—UGT2B7—Mycophenolate mofetil—systemic scleroderma	0.0244	0.0456	CbGbCtD
Losartan—UGT1A1—Mycophenolate mofetil—systemic scleroderma	0.0211	0.0394	CbGbCtD
Losartan—CYP2C8—Mometasone—systemic scleroderma	0.0155	0.029	CbGbCtD
Losartan—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0146	0.0273	CbGbCtD
Losartan—SLC22A6—Captopril—systemic scleroderma	0.0119	0.0223	CbGbCtD
Losartan—ALB—Captopril—systemic scleroderma	0.0101	0.019	CbGbCtD
Losartan—SLCO1B3—Methotrexate—systemic scleroderma	0.01	0.0188	CbGbCtD
Losartan—SLC2A9—skeletal joint—systemic scleroderma	0.0094	0.19	CbGeAlD
Losartan—CYP1A2—Pentoxifylline—systemic scleroderma	0.0081	0.0152	CbGbCtD
Losartan—ALB—Mycophenolate mofetil—systemic scleroderma	0.00798	0.0149	CbGbCtD
Losartan—CYP1A2—Leflunomide—systemic scleroderma	0.00773	0.0145	CbGbCtD
Losartan—ABCB1—Lisinopril—systemic scleroderma	0.00708	0.0133	CbGbCtD
Losartan—CYP2C9—Leflunomide—systemic scleroderma	0.00696	0.013	CbGbCtD
Losartan—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.00642	0.012	CbGbCtD
Losartan—ALB—Prednisone—systemic scleroderma	0.00638	0.0119	CbGbCtD
Losartan—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.00617	0.0115	CbGbCtD
Losartan—SLCO1B1—Methotrexate—systemic scleroderma	0.00585	0.0109	CbGbCtD
Losartan—ABCB1—Captopril—systemic scleroderma	0.0053	0.00992	CbGbCtD
Losartan—CYP2C9—cardial valve—systemic scleroderma	0.00484	0.098	CbGeAlD
Losartan—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00418	0.00781	CbGbCtD
Losartan—CYP2C19—Prednisone—systemic scleroderma	0.00414	0.00774	CbGbCtD
Losartan—ACE—forelimb zeugopod—systemic scleroderma	0.00402	0.0813	CbGeAlD
Losartan—SLC22A6—Methotrexate—systemic scleroderma	0.00376	0.00703	CbGbCtD
Losartan—ABCB1—Prednisone—systemic scleroderma	0.00334	0.00624	CbGbCtD
Losartan—ALB—Methotrexate—systemic scleroderma	0.0032	0.00599	CbGbCtD
Losartan—ACE—pulmonary artery—systemic scleroderma	0.003	0.0608	CbGeAlD
Losartan—ACE—skeletal joint—systemic scleroderma	0.00266	0.0538	CbGeAlD
Losartan—UGT2B17—digestive system—systemic scleroderma	0.00256	0.0519	CbGeAlD
Losartan—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0025	0.00468	CbGbCtD
Losartan—CYP3A4—Prednisone—systemic scleroderma	0.002	0.00374	CbGbCtD
Losartan—ACE—umbilical vein—systemic scleroderma	0.00198	0.0402	CbGeAlD
Losartan—ABCB1—Methotrexate—systemic scleroderma	0.00167	0.00313	CbGbCtD
Losartan—SLC22A12—digestive system—systemic scleroderma	0.00165	0.0334	CbGeAlD
Losartan—SLC2A9—connective tissue—systemic scleroderma	0.00157	0.0318	CbGeAlD
Losartan—AGTR1—artery—systemic scleroderma	0.00151	0.0305	CbGeAlD
Losartan—UGT1A10—digestive system—systemic scleroderma	0.00145	0.0293	CbGeAlD
Losartan—AGTR1—endothelium—systemic scleroderma	0.00127	0.0258	CbGeAlD
Losartan—AGTR1—blood vessel—systemic scleroderma	0.00117	0.0238	CbGeAlD
Losartan—ACE—artery—systemic scleroderma	0.00111	0.0225	CbGeAlD
Losartan—UGT1A3—digestive system—systemic scleroderma	0.00102	0.0207	CbGeAlD
Losartan—SLC2A9—lung—systemic scleroderma	0.000948	0.0192	CbGeAlD
Losartan—ACE—endothelium—systemic scleroderma	0.000941	0.019	CbGeAlD
Losartan—ACE—blood vessel—systemic scleroderma	0.000868	0.0176	CbGeAlD
Losartan—AGTR1—connective tissue—systemic scleroderma	0.000602	0.0122	CbGeAlD
Losartan—SLCO1B3—lung—systemic scleroderma	0.000599	0.0121	CbGeAlD
Losartan—UGT2B7—digestive system—systemic scleroderma	0.000586	0.0119	CbGeAlD
Losartan—AGTR1—smooth muscle tissue—systemic scleroderma	0.000551	0.0112	CbGeAlD
Losartan—UGT1A1—digestive system—systemic scleroderma	0.000499	0.0101	CbGeAlD
Losartan—ACE—connective tissue—systemic scleroderma	0.000445	0.009	CbGeAlD
Losartan—SLCO1B1—digestive system—systemic scleroderma	0.000415	0.0084	CbGeAlD
Losartan—AGTR1—tendon—systemic scleroderma	0.000414	0.00838	CbGeAlD
Losartan—ACE—smooth muscle tissue—systemic scleroderma	0.000407	0.00823	CbGeAlD
Losartan—AGTR1—lung—systemic scleroderma	0.000363	0.00735	CbGeAlD
Losartan—ACE—digestive system—systemic scleroderma	0.000321	0.0065	CbGeAlD
Losartan—ABCB1—blood vessel—systemic scleroderma	0.000305	0.00618	CbGeAlD
Losartan—CYP2C19—digestive system—systemic scleroderma	0.00027	0.00547	CbGeAlD
Losartan—ACE—lung—systemic scleroderma	0.000268	0.00543	CbGeAlD
Losartan—CYP1A2—digestive system—systemic scleroderma	0.000221	0.00447	CbGeAlD
Losartan—CYP3A5—digestive system—systemic scleroderma	0.000213	0.00431	CbGeAlD
Losartan—CYP2C9—digestive system—systemic scleroderma	0.00021	0.00424	CbGeAlD
Losartan—CYP1A2—lung—systemic scleroderma	0.000184	0.00373	CbGeAlD
Losartan—CYP3A5—lung—systemic scleroderma	0.000178	0.0036	CbGeAlD
Losartan—CYP3A4—digestive system—systemic scleroderma	0.00016	0.00323	CbGeAlD
Losartan—ABCB1—digestive system—systemic scleroderma	0.000113	0.00229	CbGeAlD
Losartan—ABCB1—lung—systemic scleroderma	9.45e-05	0.00191	CbGeAlD
Losartan—Shock—Lisinopril—systemic scleroderma	8.3e-05	0.00066	CcSEcCtD
Losartan—Angioedema—Mycophenolate mofetil—systemic scleroderma	8.28e-05	0.000658	CcSEcCtD
Losartan—Thrombocytopenia—Lisinopril—systemic scleroderma	8.26e-05	0.000657	CcSEcCtD
Losartan—Dyspepsia—Mycophenolic acid—systemic scleroderma	8.25e-05	0.000656	CcSEcCtD
Losartan—Tachycardia—Lisinopril—systemic scleroderma	8.24e-05	0.000655	CcSEcCtD
Losartan—Abdominal pain—Azathioprine—systemic scleroderma	8.22e-05	0.000654	CcSEcCtD
Losartan—Body temperature increased—Azathioprine—systemic scleroderma	8.22e-05	0.000654	CcSEcCtD
Losartan—Malaise—Mycophenolate mofetil—systemic scleroderma	8.17e-05	0.00065	CcSEcCtD
Losartan—Hyperhidrosis—Lisinopril—systemic scleroderma	8.16e-05	0.000649	CcSEcCtD
Losartan—Diarrhoea—Captopril—systemic scleroderma	8.15e-05	0.000648	CcSEcCtD
Losartan—Decreased appetite—Mycophenolic acid—systemic scleroderma	8.15e-05	0.000648	CcSEcCtD
Losartan—Vertigo—Mycophenolate mofetil—systemic scleroderma	8.14e-05	0.000647	CcSEcCtD
Losartan—Syncope—Mycophenolate mofetil—systemic scleroderma	8.13e-05	0.000646	CcSEcCtD
Losartan—Erectile dysfunction—Prednisone—systemic scleroderma	8.12e-05	0.000646	CcSEcCtD
Losartan—Leukopenia—Mycophenolate mofetil—systemic scleroderma	8.11e-05	0.000645	CcSEcCtD
Losartan—Feeling abnormal—Leflunomide—systemic scleroderma	8.09e-05	0.000644	CcSEcCtD
Losartan—Fatigue—Mycophenolic acid—systemic scleroderma	8.08e-05	0.000642	CcSEcCtD
Losartan—Nausea—Mometasone—systemic scleroderma	8.06e-05	0.000641	CcSEcCtD
Losartan—Anorexia—Lisinopril—systemic scleroderma	8.05e-05	0.00064	CcSEcCtD
Losartan—Gastrointestinal pain—Leflunomide—systemic scleroderma	8.03e-05	0.000639	CcSEcCtD
Losartan—Weight increased—Prednisone—systemic scleroderma	8.02e-05	0.000638	CcSEcCtD
Losartan—Ataxia—Methotrexate—systemic scleroderma	8.01e-05	0.000637	CcSEcCtD
Losartan—Pain—Mycophenolic acid—systemic scleroderma	8.01e-05	0.000637	CcSEcCtD
Losartan—Constipation—Mycophenolic acid—systemic scleroderma	8.01e-05	0.000637	CcSEcCtD
Losartan—Palpitations—Mycophenolate mofetil—systemic scleroderma	8.01e-05	0.000637	CcSEcCtD
Losartan—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	7.96e-05	0.000633	CcSEcCtD
Losartan—Hyperglycaemia—Prednisone—systemic scleroderma	7.95e-05	0.000632	CcSEcCtD
Losartan—Cough—Mycophenolate mofetil—systemic scleroderma	7.91e-05	0.000629	CcSEcCtD
Losartan—Hypotension—Lisinopril—systemic scleroderma	7.89e-05	0.000627	CcSEcCtD
Losartan—Dizziness—Captopril—systemic scleroderma	7.88e-05	0.000627	CcSEcCtD
Losartan—Urticaria—Leflunomide—systemic scleroderma	7.8e-05	0.00062	CcSEcCtD
Losartan—Abdominal pain—Leflunomide—systemic scleroderma	7.77e-05	0.000617	CcSEcCtD
Losartan—Body temperature increased—Leflunomide—systemic scleroderma	7.77e-05	0.000617	CcSEcCtD
Losartan—Feeling abnormal—Mycophenolic acid—systemic scleroderma	7.72e-05	0.000614	CcSEcCtD
Losartan—Arthralgia—Mycophenolate mofetil—systemic scleroderma	7.71e-05	0.000613	CcSEcCtD
Losartan—Chest pain—Mycophenolate mofetil—systemic scleroderma	7.71e-05	0.000613	CcSEcCtD
Losartan—Myalgia—Mycophenolate mofetil—systemic scleroderma	7.71e-05	0.000613	CcSEcCtD
Losartan—Neuropathy peripheral—Prednisone—systemic scleroderma	7.7e-05	0.000613	CcSEcCtD
Losartan—Breast disorder—Methotrexate—systemic scleroderma	7.7e-05	0.000612	CcSEcCtD
Losartan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	7.69e-05	0.000611	CcSEcCtD
Losartan—Anxiety—Mycophenolate mofetil—systemic scleroderma	7.69e-05	0.000611	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	7.68e-05	0.00061	CcSEcCtD
Losartan—Hypersensitivity—Azathioprine—systemic scleroderma	7.66e-05	0.000609	CcSEcCtD
Losartan—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	7.66e-05	0.000609	CcSEcCtD
Losartan—Insomnia—Lisinopril—systemic scleroderma	7.63e-05	0.000607	CcSEcCtD
Losartan—Discomfort—Mycophenolate mofetil—systemic scleroderma	7.62e-05	0.000606	CcSEcCtD
Losartan—Paraesthesia—Lisinopril—systemic scleroderma	7.58e-05	0.000603	CcSEcCtD
Losartan—Vomiting—Captopril—systemic scleroderma	7.58e-05	0.000603	CcSEcCtD
Losartan—Dry mouth—Mycophenolate mofetil—systemic scleroderma	7.54e-05	0.0006	CcSEcCtD
Losartan—Dyspnoea—Lisinopril—systemic scleroderma	7.52e-05	0.000598	CcSEcCtD
Losartan—Rash—Captopril—systemic scleroderma	7.51e-05	0.000597	CcSEcCtD
Losartan—Dermatitis—Captopril—systemic scleroderma	7.51e-05	0.000597	CcSEcCtD
Losartan—Somnolence—Lisinopril—systemic scleroderma	7.5e-05	0.000597	CcSEcCtD
Losartan—Headache—Captopril—systemic scleroderma	7.47e-05	0.000594	CcSEcCtD
Losartan—Confusional state—Mycophenolate mofetil—systemic scleroderma	7.46e-05	0.000593	CcSEcCtD
Losartan—Dyspepsia—Lisinopril—systemic scleroderma	7.43e-05	0.000591	CcSEcCtD
Losartan—Body temperature increased—Mycophenolic acid—systemic scleroderma	7.41e-05	0.000589	CcSEcCtD
Losartan—Abdominal pain—Mycophenolic acid—systemic scleroderma	7.41e-05	0.000589	CcSEcCtD
Losartan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	7.4e-05	0.000588	CcSEcCtD
Losartan—Oedema—Mycophenolate mofetil—systemic scleroderma	7.4e-05	0.000588	CcSEcCtD
Losartan—Infection—Mycophenolate mofetil—systemic scleroderma	7.35e-05	0.000584	CcSEcCtD
Losartan—Decreased appetite—Lisinopril—systemic scleroderma	7.34e-05	0.000583	CcSEcCtD
Losartan—Eosinophilia—Methotrexate—systemic scleroderma	7.29e-05	0.00058	CcSEcCtD
Losartan—Fatigue—Lisinopril—systemic scleroderma	7.28e-05	0.000579	CcSEcCtD
Losartan—Shock—Mycophenolate mofetil—systemic scleroderma	7.28e-05	0.000578	CcSEcCtD
Losartan—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	7.25e-05	0.000577	CcSEcCtD
Losartan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	7.24e-05	0.000576	CcSEcCtD
Losartan—Hypersensitivity—Leflunomide—systemic scleroderma	7.24e-05	0.000575	CcSEcCtD
Losartan—Pancreatitis—Methotrexate—systemic scleroderma	7.22e-05	0.000574	CcSEcCtD
Losartan—Pain—Lisinopril—systemic scleroderma	7.22e-05	0.000574	CcSEcCtD
Losartan—Constipation—Lisinopril—systemic scleroderma	7.22e-05	0.000574	CcSEcCtD
Losartan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	7.22e-05	0.000574	CcSEcCtD
Losartan—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	7.15e-05	0.000568	CcSEcCtD
Losartan—Diarrhoea—Azathioprine—systemic scleroderma	7.12e-05	0.000566	CcSEcCtD
Losartan—Nausea—Captopril—systemic scleroderma	7.08e-05	0.000563	CcSEcCtD
Losartan—Anorexia—Mycophenolate mofetil—systemic scleroderma	7.05e-05	0.00056	CcSEcCtD
Losartan—Asthenia—Leflunomide—systemic scleroderma	7.05e-05	0.00056	CcSEcCtD
Losartan—Feeling abnormal—Lisinopril—systemic scleroderma	6.96e-05	0.000553	CcSEcCtD
Losartan—Pruritus—Leflunomide—systemic scleroderma	6.95e-05	0.000553	CcSEcCtD
Losartan—Hypotension—Mycophenolate mofetil—systemic scleroderma	6.91e-05	0.000549	CcSEcCtD
Losartan—Gastrointestinal pain—Lisinopril—systemic scleroderma	6.9e-05	0.000549	CcSEcCtD
Losartan—Dizziness—Azathioprine—systemic scleroderma	6.88e-05	0.000547	CcSEcCtD
Losartan—Upper respiratory tract infection—Methotrexate—systemic scleroderma	6.85e-05	0.000544	CcSEcCtD
Losartan—Erectile dysfunction—Methotrexate—systemic scleroderma	6.79e-05	0.000539	CcSEcCtD
Losartan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	6.74e-05	0.000536	CcSEcCtD
Losartan—Photosensitivity reaction—Methotrexate—systemic scleroderma	6.72e-05	0.000535	CcSEcCtD
Losartan—Asthenia—Mycophenolic acid—systemic scleroderma	6.72e-05	0.000535	CcSEcCtD
Losartan—Diarrhoea—Leflunomide—systemic scleroderma	6.72e-05	0.000534	CcSEcCtD
Losartan—Urticaria—Lisinopril—systemic scleroderma	6.71e-05	0.000533	CcSEcCtD
Losartan—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.69e-05	0.000532	CcSEcCtD
Losartan—Body temperature increased—Lisinopril—systemic scleroderma	6.67e-05	0.000531	CcSEcCtD
Losartan—Abdominal pain—Lisinopril—systemic scleroderma	6.67e-05	0.000531	CcSEcCtD
Losartan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	6.64e-05	0.000528	CcSEcCtD
Losartan—Pruritus—Mycophenolic acid—systemic scleroderma	6.63e-05	0.000527	CcSEcCtD
Losartan—Vomiting—Azathioprine—systemic scleroderma	6.61e-05	0.000526	CcSEcCtD
Losartan—Pneumonia—Methotrexate—systemic scleroderma	6.61e-05	0.000525	CcSEcCtD
Losartan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.59e-05	0.000524	CcSEcCtD
Losartan—Somnolence—Mycophenolate mofetil—systemic scleroderma	6.57e-05	0.000523	CcSEcCtD
Losartan—Rash—Azathioprine—systemic scleroderma	6.56e-05	0.000521	CcSEcCtD
Losartan—Dermatitis—Azathioprine—systemic scleroderma	6.55e-05	0.000521	CcSEcCtD
Losartan—Flushing—Prednisone—systemic scleroderma	6.55e-05	0.000521	CcSEcCtD
Losartan—Headache—Azathioprine—systemic scleroderma	6.52e-05	0.000518	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	6.51e-05	0.000518	CcSEcCtD
Losartan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	6.51e-05	0.000518	CcSEcCtD
Losartan—Dizziness—Leflunomide—systemic scleroderma	6.5e-05	0.000516	CcSEcCtD
Losartan—Renal failure—Methotrexate—systemic scleroderma	6.46e-05	0.000513	CcSEcCtD
Losartan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	6.43e-05	0.000511	CcSEcCtD
Losartan—Diarrhoea—Mycophenolic acid—systemic scleroderma	6.41e-05	0.00051	CcSEcCtD
Losartan—Angiopathy—Prednisone—systemic scleroderma	6.4e-05	0.000509	CcSEcCtD
Losartan—Conjunctivitis—Methotrexate—systemic scleroderma	6.38e-05	0.000508	CcSEcCtD
Losartan—Pain—Mycophenolate mofetil—systemic scleroderma	6.32e-05	0.000503	CcSEcCtD
Losartan—Constipation—Mycophenolate mofetil—systemic scleroderma	6.32e-05	0.000503	CcSEcCtD
Losartan—Arrhythmia—Prednisone—systemic scleroderma	6.3e-05	0.000501	CcSEcCtD
Losartan—Sweating—Methotrexate—systemic scleroderma	6.3e-05	0.000501	CcSEcCtD
Losartan—Vomiting—Leflunomide—systemic scleroderma	6.25e-05	0.000497	CcSEcCtD
Losartan—Alopecia—Prednisone—systemic scleroderma	6.23e-05	0.000496	CcSEcCtD
Losartan—Hypersensitivity—Lisinopril—systemic scleroderma	6.22e-05	0.000494	CcSEcCtD
Losartan—Dizziness—Mycophenolic acid—systemic scleroderma	6.2e-05	0.000493	CcSEcCtD
Losartan—Epistaxis—Methotrexate—systemic scleroderma	6.2e-05	0.000493	CcSEcCtD
Losartan—Rash—Leflunomide—systemic scleroderma	6.19e-05	0.000492	CcSEcCtD
Losartan—Dermatitis—Leflunomide—systemic scleroderma	6.19e-05	0.000492	CcSEcCtD
Losartan—Nausea—Azathioprine—systemic scleroderma	6.18e-05	0.000491	CcSEcCtD
Losartan—Headache—Leflunomide—systemic scleroderma	6.15e-05	0.000489	CcSEcCtD
Losartan—Erythema—Prednisone—systemic scleroderma	6.14e-05	0.000488	CcSEcCtD
Losartan—Agranulocytosis—Methotrexate—systemic scleroderma	6.13e-05	0.000487	CcSEcCtD
Losartan—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	6.09e-05	0.000485	CcSEcCtD
Losartan—Asthenia—Lisinopril—systemic scleroderma	6.06e-05	0.000481	CcSEcCtD
Losartan—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	6.05e-05	0.000481	CcSEcCtD
Losartan—Pruritus—Lisinopril—systemic scleroderma	5.97e-05	0.000475	CcSEcCtD
Losartan—Vomiting—Mycophenolic acid—systemic scleroderma	5.96e-05	0.000474	CcSEcCtD
Losartan—Rash—Mycophenolic acid—systemic scleroderma	5.91e-05	0.00047	CcSEcCtD
Losartan—Dermatitis—Mycophenolic acid—systemic scleroderma	5.9e-05	0.000469	CcSEcCtD
Losartan—Hepatitis—Methotrexate—systemic scleroderma	5.9e-05	0.000469	CcSEcCtD
Losartan—Urticaria—Mycophenolate mofetil—systemic scleroderma	5.87e-05	0.000467	CcSEcCtD
Losartan—Headache—Mycophenolic acid—systemic scleroderma	5.87e-05	0.000467	CcSEcCtD
Losartan—Pharyngitis—Methotrexate—systemic scleroderma	5.85e-05	0.000465	CcSEcCtD
Losartan—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	5.85e-05	0.000465	CcSEcCtD
Losartan—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	5.85e-05	0.000465	CcSEcCtD
Losartan—Nausea—Leflunomide—systemic scleroderma	5.83e-05	0.000464	CcSEcCtD
Losartan—Vision blurred—Prednisone—systemic scleroderma	5.79e-05	0.00046	CcSEcCtD
Losartan—Diarrhoea—Lisinopril—systemic scleroderma	5.77e-05	0.000459	CcSEcCtD
Losartan—Ill-defined disorder—Prednisone—systemic scleroderma	5.7e-05	0.000453	CcSEcCtD
Losartan—Anaemia—Prednisone—systemic scleroderma	5.68e-05	0.000451	CcSEcCtD
Losartan—Agitation—Prednisone—systemic scleroderma	5.64e-05	0.000449	CcSEcCtD
Losartan—Angioedema—Prednisone—systemic scleroderma	5.61e-05	0.000446	CcSEcCtD
Losartan—Dizziness—Lisinopril—systemic scleroderma	5.58e-05	0.000444	CcSEcCtD
Losartan—Erythema multiforme—Methotrexate—systemic scleroderma	5.58e-05	0.000443	CcSEcCtD
Losartan—Nausea—Mycophenolic acid—systemic scleroderma	5.57e-05	0.000443	CcSEcCtD
Losartan—Malaise—Prednisone—systemic scleroderma	5.54e-05	0.00044	CcSEcCtD
Losartan—Vertigo—Prednisone—systemic scleroderma	5.52e-05	0.000439	CcSEcCtD
Losartan—Syncope—Prednisone—systemic scleroderma	5.51e-05	0.000438	CcSEcCtD
Losartan—Tinnitus—Methotrexate—systemic scleroderma	5.5e-05	0.000437	CcSEcCtD
Losartan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.45e-05	0.000433	CcSEcCtD
Losartan—Loss of consciousness—Prednisone—systemic scleroderma	5.4e-05	0.000429	CcSEcCtD
Losartan—Vomiting—Lisinopril—systemic scleroderma	5.37e-05	0.000427	CcSEcCtD
Losartan—Angiopathy—Methotrexate—systemic scleroderma	5.35e-05	0.000425	CcSEcCtD
Losartan—Rash—Lisinopril—systemic scleroderma	5.32e-05	0.000423	CcSEcCtD
Losartan—Dermatitis—Lisinopril—systemic scleroderma	5.32e-05	0.000423	CcSEcCtD
Losartan—Asthenia—Mycophenolate mofetil—systemic scleroderma	5.31e-05	0.000422	CcSEcCtD
Losartan—Headache—Lisinopril—systemic scleroderma	5.29e-05	0.00042	CcSEcCtD
Losartan—Pruritus—Mycophenolate mofetil—systemic scleroderma	5.23e-05	0.000416	CcSEcCtD
Losartan—Arthralgia—Prednisone—systemic scleroderma	5.23e-05	0.000416	CcSEcCtD
Losartan—Myalgia—Prednisone—systemic scleroderma	5.23e-05	0.000416	CcSEcCtD
Losartan—Anxiety—Prednisone—systemic scleroderma	5.21e-05	0.000414	CcSEcCtD
Losartan—Alopecia—Methotrexate—systemic scleroderma	5.21e-05	0.000414	CcSEcCtD
Losartan—Discomfort—Prednisone—systemic scleroderma	5.17e-05	0.000411	CcSEcCtD
Losartan—Erythema—Methotrexate—systemic scleroderma	5.13e-05	0.000408	CcSEcCtD
Losartan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	5.06e-05	0.000402	CcSEcCtD
Losartan—Dysgeusia—Methotrexate—systemic scleroderma	5.03e-05	0.0004	CcSEcCtD
Losartan—Nausea—Lisinopril—systemic scleroderma	5.01e-05	0.000399	CcSEcCtD
Losartan—Oedema—Prednisone—systemic scleroderma	5.01e-05	0.000399	CcSEcCtD
Losartan—Anaphylactic shock—Prednisone—systemic scleroderma	5.01e-05	0.000399	CcSEcCtD
Losartan—Infection—Prednisone—systemic scleroderma	4.98e-05	0.000396	CcSEcCtD
Losartan—Back pain—Methotrexate—systemic scleroderma	4.97e-05	0.000395	CcSEcCtD
Losartan—Shock—Prednisone—systemic scleroderma	4.93e-05	0.000392	CcSEcCtD
Losartan—Nervous system disorder—Prednisone—systemic scleroderma	4.92e-05	0.000391	CcSEcCtD
Losartan—Tachycardia—Prednisone—systemic scleroderma	4.89e-05	0.000389	CcSEcCtD
Losartan—Dizziness—Mycophenolate mofetil—systemic scleroderma	4.89e-05	0.000389	CcSEcCtD
Losartan—Hyperhidrosis—Prednisone—systemic scleroderma	4.85e-05	0.000385	CcSEcCtD
Losartan—Vision blurred—Methotrexate—systemic scleroderma	4.84e-05	0.000385	CcSEcCtD
Losartan—Anorexia—Prednisone—systemic scleroderma	4.78e-05	0.00038	CcSEcCtD
Losartan—Ill-defined disorder—Methotrexate—systemic scleroderma	4.76e-05	0.000379	CcSEcCtD
Losartan—Anaemia—Methotrexate—systemic scleroderma	4.74e-05	0.000377	CcSEcCtD
Losartan—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.7e-05	0.000374	CcSEcCtD
Losartan—Rash—Mycophenolate mofetil—systemic scleroderma	4.66e-05	0.000371	CcSEcCtD
Losartan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.66e-05	0.00037	CcSEcCtD
Losartan—Headache—Mycophenolate mofetil—systemic scleroderma	4.63e-05	0.000368	CcSEcCtD
Losartan—Malaise—Methotrexate—systemic scleroderma	4.63e-05	0.000368	CcSEcCtD
Losartan—Vertigo—Methotrexate—systemic scleroderma	4.61e-05	0.000367	CcSEcCtD
Losartan—Leukopenia—Methotrexate—systemic scleroderma	4.59e-05	0.000365	CcSEcCtD
Losartan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.57e-05	0.000363	CcSEcCtD
Losartan—Insomnia—Prednisone—systemic scleroderma	4.53e-05	0.00036	CcSEcCtD
Losartan—Paraesthesia—Prednisone—systemic scleroderma	4.5e-05	0.000358	CcSEcCtD
Losartan—Cough—Methotrexate—systemic scleroderma	4.48e-05	0.000356	CcSEcCtD
Losartan—Dyspepsia—Prednisone—systemic scleroderma	4.41e-05	0.000351	CcSEcCtD
Losartan—Nausea—Mycophenolate mofetil—systemic scleroderma	4.39e-05	0.000349	CcSEcCtD
Losartan—Myalgia—Methotrexate—systemic scleroderma	4.37e-05	0.000347	CcSEcCtD
Losartan—Arthralgia—Methotrexate—systemic scleroderma	4.37e-05	0.000347	CcSEcCtD
Losartan—Chest pain—Methotrexate—systemic scleroderma	4.37e-05	0.000347	CcSEcCtD
Losartan—Decreased appetite—Prednisone—systemic scleroderma	4.36e-05	0.000346	CcSEcCtD
Losartan—Fatigue—Prednisone—systemic scleroderma	4.32e-05	0.000344	CcSEcCtD
Losartan—Discomfort—Methotrexate—systemic scleroderma	4.32e-05	0.000343	CcSEcCtD
Losartan—Constipation—Prednisone—systemic scleroderma	4.29e-05	0.000341	CcSEcCtD
Losartan—Confusional state—Methotrexate—systemic scleroderma	4.22e-05	0.000336	CcSEcCtD
Losartan—Anaphylactic shock—Methotrexate—systemic scleroderma	4.19e-05	0.000333	CcSEcCtD
Losartan—Infection—Methotrexate—systemic scleroderma	4.16e-05	0.000331	CcSEcCtD
Losartan—Feeling abnormal—Prednisone—systemic scleroderma	4.13e-05	0.000328	CcSEcCtD
Losartan—Nervous system disorder—Methotrexate—systemic scleroderma	4.11e-05	0.000327	CcSEcCtD
Losartan—Thrombocytopenia—Methotrexate—systemic scleroderma	4.1e-05	0.000326	CcSEcCtD
Losartan—Gastrointestinal pain—Prednisone—systemic scleroderma	4.1e-05	0.000326	CcSEcCtD
Losartan—Hyperhidrosis—Methotrexate—systemic scleroderma	4.05e-05	0.000322	CcSEcCtD
Losartan—Anorexia—Methotrexate—systemic scleroderma	3.99e-05	0.000318	CcSEcCtD
Losartan—Urticaria—Prednisone—systemic scleroderma	3.98e-05	0.000317	CcSEcCtD
Losartan—Abdominal pain—Prednisone—systemic scleroderma	3.96e-05	0.000315	CcSEcCtD
Losartan—Body temperature increased—Prednisone—systemic scleroderma	3.96e-05	0.000315	CcSEcCtD
Losartan—Hypotension—Methotrexate—systemic scleroderma	3.91e-05	0.000311	CcSEcCtD
Losartan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.82e-05	0.000303	CcSEcCtD
Losartan—Insomnia—Methotrexate—systemic scleroderma	3.79e-05	0.000301	CcSEcCtD
Losartan—Paraesthesia—Methotrexate—systemic scleroderma	3.76e-05	0.000299	CcSEcCtD
Losartan—Dyspnoea—Methotrexate—systemic scleroderma	3.73e-05	0.000297	CcSEcCtD
Losartan—Somnolence—Methotrexate—systemic scleroderma	3.72e-05	0.000296	CcSEcCtD
Losartan—Hypersensitivity—Prednisone—systemic scleroderma	3.69e-05	0.000294	CcSEcCtD
Losartan—Dyspepsia—Methotrexate—systemic scleroderma	3.69e-05	0.000293	CcSEcCtD
Losartan—Decreased appetite—Methotrexate—systemic scleroderma	3.64e-05	0.00029	CcSEcCtD
Losartan—Fatigue—Methotrexate—systemic scleroderma	3.61e-05	0.000287	CcSEcCtD
Losartan—Asthenia—Prednisone—systemic scleroderma	3.6e-05	0.000286	CcSEcCtD
Losartan—Pain—Methotrexate—systemic scleroderma	3.58e-05	0.000285	CcSEcCtD
Losartan—Pruritus—Prednisone—systemic scleroderma	3.55e-05	0.000282	CcSEcCtD
Losartan—Feeling abnormal—Methotrexate—systemic scleroderma	3.45e-05	0.000274	CcSEcCtD
Losartan—Diarrhoea—Prednisone—systemic scleroderma	3.43e-05	0.000273	CcSEcCtD
Losartan—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.43e-05	0.000272	CcSEcCtD
Losartan—Urticaria—Methotrexate—systemic scleroderma	3.33e-05	0.000265	CcSEcCtD
Losartan—Dizziness—Prednisone—systemic scleroderma	3.31e-05	0.000264	CcSEcCtD
Losartan—Abdominal pain—Methotrexate—systemic scleroderma	3.31e-05	0.000263	CcSEcCtD
Losartan—Body temperature increased—Methotrexate—systemic scleroderma	3.31e-05	0.000263	CcSEcCtD
Losartan—Vomiting—Prednisone—systemic scleroderma	3.19e-05	0.000253	CcSEcCtD
Losartan—Rash—Prednisone—systemic scleroderma	3.16e-05	0.000251	CcSEcCtD
Losartan—Dermatitis—Prednisone—systemic scleroderma	3.16e-05	0.000251	CcSEcCtD
Losartan—Headache—Prednisone—systemic scleroderma	3.14e-05	0.00025	CcSEcCtD
Losartan—Hypersensitivity—Methotrexate—systemic scleroderma	3.09e-05	0.000245	CcSEcCtD
Losartan—Asthenia—Methotrexate—systemic scleroderma	3.01e-05	0.000239	CcSEcCtD
Losartan—Nausea—Prednisone—systemic scleroderma	2.98e-05	0.000237	CcSEcCtD
Losartan—Pruritus—Methotrexate—systemic scleroderma	2.96e-05	0.000236	CcSEcCtD
Losartan—Diarrhoea—Methotrexate—systemic scleroderma	2.87e-05	0.000228	CcSEcCtD
Losartan—Dizziness—Methotrexate—systemic scleroderma	2.77e-05	0.00022	CcSEcCtD
Losartan—Vomiting—Methotrexate—systemic scleroderma	2.66e-05	0.000212	CcSEcCtD
Losartan—Rash—Methotrexate—systemic scleroderma	2.64e-05	0.00021	CcSEcCtD
Losartan—Dermatitis—Methotrexate—systemic scleroderma	2.64e-05	0.00021	CcSEcCtD
Losartan—Headache—Methotrexate—systemic scleroderma	2.62e-05	0.000209	CcSEcCtD
Losartan—Nausea—Methotrexate—systemic scleroderma	2.49e-05	0.000198	CcSEcCtD
